Winter spotlight
SUppliers can cost-effectively
SA cannabis script approval Labelling standards
A new study published by the
showcase their wares in Pharmacy Doctors in South Australia can supply of Schedule 8 medicines also BMJ last week has found using
Dailys upcoming Winter Spotlight now prescribe medicinal cannabis applying to S8 medicinal cannabis standardised medicine packaging
feature, which kicks off next week. for some patients without requiring products. could improve efficiencies while still
The promotion features four a section 18A authority, under Notably, under the guidelines maintaining safety.
items on a page, with insertions new guidelines clarifying access released this week an authority is The Norwegian pharmacy
including an image, a brief pathways to the items. not required for patients aged 70 research featured standardised
description and a call to action for Under this pathway patients can years or older; who are Notified medicine packaging with
phone, email or website ordering. be supplied medicinal cannabis Palliative Care Patients; or who are prominent placement of the drug
To have your products included products prescribed by their not drug dependent, for regular use name and strength, written in black
call 1300 799 220 or email Mel on medical specialist and dispensed for less than two months. on a white background, and placed
advertising@pharmacydaily.com.au. by a pharmacist, with existing SA SA Health noted that currently in the upper right corner of the
Controlled Substances legislation medical practitioners must apply package.
regulating the prescribing and to the Commonwealth Department Using the redesigned labels,
New dermatitis course of Health for approval to supply nurses and pharmacy technicians
Guild Learning and Development and where necessary import, an prepared medicines in a simulated
has announced that, in partnership Novartis HRT short unregistered medicinal cannabis environment, with participants
with skincare specialist Novartis has confirmed that product. working significantly faster with the
company Ego Pharmaceuticals, supplies of hormone replacement standardised packaging.
it has developed a new online
training module, Quality use of
therapy patches continue to be JPPR edition out The researchers said the new
unreliable due to manufacturing labels also saw error rates drop
topical corticosteroids in atopic The newest edition of the Society from 9.1% to 6.5% - bmj.com.
issues, with the company
dermatitis. of Hospital Pharmacists of Australia
anticipating a return to stable
Pharmacy Guild of Australia Journal of Pharmacy Practice and
supply of items such as Estradot
national president George and Estalis by the middle of 2017.
Research (JPPR) is now available PBAC agenda out
Tambassis said the course would online, with the publication
The Health Department has
provide community pharmacists including details of the first
released the agenda for the Jul
with best-practice guidelines for Antizol approval Australian case report into the side
2017 Pharmaceutical Benefits
the use of topical corticosteroids. AnTizol (fomepizol) has received effects of nivolumab, used to treat
Advisory Committee meeting,
The term, use sparingly is no regulatory approval in Australia and inoperable or metastatic melanoma.
which will consider a whopping 60-
longer widely used by GPs and is now available for the treatment Other articles cover electronic
plus submissions and reports.
dermatologists, Tambassis said. of methanol and ethylene glycol medication management,
Comments on agenda items are
The course was designed for toxicities. telehealth, advanced pharmacy
solicited from stakeholders with a
pharmacists within the DERMIS The product is distributed locally practice and much more - for
closing date of 07 Jun 2017 - see
program - visit myCPD.org.au. by AFT Pharmaceuticals. details CLICK HERE.
www.pbs.gov.au.
The original
probiotic PLUS
Always read the label. Use only as directed.
Pharmacy Daily Thursday 27th April 2017 t 1300 799 220 w www.pharmacydaily.com.au page 1
Follow us
on social media
Just one click away from keeping up
to date with all the Pharmacy Daily
Thursday 27 Apr 2017 breaking news as it comes to hand
Pharmacy Daily is Australias favourite pharmacy industry publication. Publisher/Editor in chief: Bruce Piper Editorial: info@pharmacydaily.com.au
Sign up free at www.pharmacydaily.com.au. Managing Editor: Jon Murrie
Postal address: PO Box 1010, Epping, NSW 1710 Australia Reporter: Mal Smith
Street address: Level 2, Suite 1 64 Talavera Rd, Macquarie Park NSW 2113 Australia Contributors: Matt Bell, Rebecca Le Bas, Jasmine ODonoghue
Advertising and Marketing: Sean Harrigan and Melanie Tchakmadjian advertising@pharmacydaily.com.au
P: 1300 799 220 (+61 2 8007 6760) F: 1300 799 221 (+61 2 8007 6769)
Business Manager: Jenny Piper accounts@pharmacydaily.com.au
Part of the Business Publishing Group.
business events news
Pharmacy Daily is a publication of Pharmacy Daily Pty Ltd ABN 97 124 094 604. All content fully protected by copyright. Please obtain written permission to reproduce any material. While every care has been taken in the preparation of
the newsletter no liability can be accepted for errors or omissions. Information is published in good faith to stimulate independent investigation of the matters canvassed. Responsibility for editorial comment is taken by Bruce Piper.
Pharmacy Daily Thursday 27th April 2017 t 1300 799 220 w www.pharmacydaily.com.au page 2